Non-Small Cell Lung Cancer

Research from S. Akamine and co-researchers yields new findings on non-small cell lung cancer

Published in Hospital Law Weekly, March 27th, 2008

"The treatment strategy for patients with non-small-cell lung cancer (NSCLC) involving ipsilateral mediastinal lymph nodes is still controversial. We performed a phase II feasibility study of induction chemotherapy followed by surgery for patients with pathologic N2 NSCLC," researchers in Oita, Japan report.

"Patients with mediastinoscopy-positive stage IIIA N2 NSCLC received 2 cycles of cisplatin 80 mg/m(2), vinorelbine 25 mg/m(2), and mitomycin-C 8 mg/m(2). Patients without progressive disease underwent thoracotomy and lobectomy with lymph node dissections 2-4 weeks later. From January 2000 to July 2004, 24 eligible patients (15 men, 9 women) were enrolled. Induction...

Want to see the full article?

Purchase this article for only $3.00

We're a pay-per-view site for premium content. If you'd like to purchase this article, it's only $3.00.

Welcome to NewsRx!

Learn more about a six-week, no-risk free trial of Hospital Law Weekly

Source: Hospital Law Weekly (2008-03-27)

NewsRx is Social

Top Medical Newsletters

Awards

Best Health/Healthcare Content, 2012
Best Health/Healthcare Content, 2011
Best e-Business Site, 2010
Best e-Business Site, 2009
Best e-Business Site, 2008
Best e-Business Site, 2007
Best e-Business Site, 2006
Best Healthcare Content, 2005
Best Overall Internet Site, 2005
Best Interactive Site, 2005

Facts & Stats

NewsRx also is available at LexisNexis, Gale, ProQuest, Factiva, Dialog, Thomson Reuters, NewsEdge, and Dow Jones.

Google 2010 PageRank: #2 Among Top Health News and Media Publications
Google 2010 PageRank: #2 Among Top Science Publications in Biology/Physiology
Google 2010 PageRank: #2 Among Top News and Media for the Business of Pharmaceuticals
Amazon's Alexa 2010 PageRank: #2 News and Media Site for the Pharmaceutical Industry